| CAS ID: | 210101-16-9 |
| Molecular Formula: | C32H26N4O2 |
| Molecular Weight: | 498.6 g/mol |
| Monoisotopic Mass: | 498.2056 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | YM087 | CONIVAPTAN HYDROCHLORIDE | CI-1025 | CONIVAPTAN | VAPRISOL |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C32H26N4O2/c1-21-33-28-19-20-36(29-14-8-7-13-27(29)30(28)34-21)32(38)23-15-17-24(18-16-23)35-31(37)26-12-6-5-11-25(26)22-9-3-2-4-10-22/h2-18H,19-20H2,1H3,(H,33,34)(H,35,37) | See All |
| InChI Key: | IKENVDNFQMCRTR-UHFFFAOYSA-N | |
| Smiles: | Cc1nc2c(CCN(C(=O)c3ccc(NC(=O)c4ccccc4c5ccccc5)cc3)c6ccccc26)[nH]1 | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00592475 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | January 14, 2008 | Last Verified | May 15, 2014 |
| Sponsor | Cumberland Pharmaceuticals | ||
| PubChem: | 151171 |
| ChEMBL: | CHEMBL1755 |